Invention Grant
- Patent Title: Treprostinil derivative compounds and methods of using same
-
Application No.: US15686422Application Date: 2017-08-25
-
Publication No.: US10344012B2Publication Date: 2019-07-09
- Inventor: Cyrus K. Becker , Meenakshi S. Venkatraman , Xiaoming Zhang , Jürg Pfister
- Applicant: CORSAIR PHARMA, INC.
- Applicant Address: US CA South Francisco
- Assignee: Corsair Pharma, Inc.
- Current Assignee: Corsair Pharma, Inc.
- Current Assignee Address: US CA South Francisco
- Agency: The Marbury Law Group, PLLC
- Main IPC: C07D313/00
- IPC: C07D313/00 ; C07C69/712 ; C07D317/40 ; C07D321/00 ; C07D453/02 ; C07D257/06 ; C07D263/24 ; C07D265/30 ; C07D295/088 ; C07D211/60 ; C07D295/145 ; C07D307/20 ; C07C219/16 ; C07C235/20 ; C07C59/54 ; C07C69/734 ; C07C235/34 ; C07D207/08 ; C07D263/26 ; C07D317/34 ; A61K9/70 ; A61K31/165 ; A61K31/216 ; A61K31/335 ; C07C59/31
Abstract:
Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
Public/Granted literature
- US20180086730A1 TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME Public/Granted day:2018-03-29
Information query
